Reliable power is no longer simply an operational requirement. It has become part of the economic development conversation.

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Synokem Pharmaceuticals Ltd. outlines its four-decade journey, manufacturing infrastructure, research capabilities, strategic expansion and focus on pharmaceutical development as a CDMO.

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Software enhancements for medical device, pharmaceutical and biotechnology teams support regulatory readiness, traceability ...

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

Patient advocates in remission from MCL and FL discuss their experiences with treatment, as well as their views on CAR-T ...

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was ...

China's biotech industry is on a rapid rise, with the first approved brain-computer interface and massive growth in drug ...

A' Medical Devices and Medical Equipment Design Awards 2026 invites medical technology innovators and healthcare ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...